From Rallybio Lands $145M to Alter Course of FNAIT and More Rare Diseases:

RAL101_Img_001_Blood_Vessel_maternal_Therapy_Antibody_a
RAL101_Img_001_Blood_Vessel_maternal_Therapy_Antibody_a

Image of RLYB211 by Rallybio.